HEALTH OF WOMAN.2018.2(128):9–15; doi 10.15574/HW.2018.128.9

Romanenko T. G. , Dovbnia T. V.
Shupyk National Medical Academy of Postgraduate Education, Kiev

The aim of this lecture is to promote the formation of modern ideas about papillomavirus infection, the history of the discovery of IDPs and its role in the development of cervical cancer, pathogenesis and stages of the clinical course of PVI. Also, emphasized on the diagnosis and prevention of PVI and on recommendations for screening in women of different age groups, options for treatment regimes are considered.
Key words: HPV infection, cervical cancer, screening, the Bethesda system, vaccination from HPV.

REFERENCES

1. Bohman YaV. 2002. Rukovodstvo po onkoginekologii.

2. Vishnevskaya EE. 2002. Predopuholevyie zabolevaniya i zlokachestvennyie opuholi zhenskih polovyih organov.

3. Kohanevich EV, Ganina KP, Sumenko VV. 1998. Kolpotservikoskopiya. Atlas.

4. Polyakova VA. 2001. Onkoginekologiya.

5. Rukovodstvo k prakticheskim zanyatiyam po ginekologii. Pod red. VE Radzinskogo. 2005.

6. Hvorostuhina SA. 2008. Polovyie infektsii u zhenschin:126.

7. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention/2013.

8. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM & Gertig DM. 2011. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 377;9783:2085-2092. https://doi.org/10.1016/S0140-6736(11)60551-5

9. Castellsague X, Munoz N, Pitisuttithum P, Ferris D, Monsonego J, Ault K, Luna J, Myers E, Mallary S, Bautista OM, Bryan J, Vuocolo S, Haupt RM & Saah A. 2011. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. Br J Cancer 105;1:28-37. https://doi.org/10.1038/bjc.2011.185; PMid:21629249 PMCid:PMC3137403

10. Couto E, Sæterdal I, Lene Kristine Juvet LK & Klemp M. 2014. HPV catch-up vaccination of young women: a systematic review and meta-analysis. BMC Public Health 14:867. Available from (accessed 16/03/2015): http://www.biomedcentral.com/1471-2458/14/867

11. ECDC (2012). European Centre for Disease Prevention and Control. Introduction of HPV vaccines in EU countries – an update. Stockholm. Available from (accessed 10/04/2015): http://ecdc.europa.eu/en/publications/publications/20120905_gui_hpv_vaccine_update.pdf

12. HPA (2010). Health Protection Agency. Vaccine in pregnancy surveillance. Available from (accessed 04/06/2014): http://www.hpa.org.uk/webw/HPAweb&Page&HPAwebAutoListName/Page/1221202947595?p=1221202947595

13. Seme K, Maver PJ, Korać T, Canton A, Částková J, Dimitrov G, Filippova I, Hudecová H, Iljazović E, Kaić B, Kesić V, Kuprevičienė N, Laušević D, Molnár Z, Perevoščikovs J, Spaczynski M, Stefanova V, Učakar V & Poljak M. 2013. Current status of human papillomavirus vaccination implementation in central and eastern Europe. Acta Dermatovenerol Alp Pannonica Adriat 22;1:21–25.